11011 TORREYANA RD # 219 SUITE 219 SAN DIEGO, CA 92121 Get Directions
11011 TORREYANA RD # 219 SUITE 219 SAN DIEGO, CA 92121 Get Directions
Telephus is developing TPH 101, a first-in-class humanized monoclonal antibody to prevent Staphylococcus reinfection and accompanying osteomyelitis in patients receiving total hip arthroplasty (THA) or total knee arthroplasty (TKA) septic revision surgery. Focused on preventing the early events that lead to biofilm deposition on implantable devices, we are dedicated to improving outcomes for joint replacement procedures â?? a necessity where there is a growing unmet medical need for reducing complications from arthroplasty procedures in a population where people are living longer, more active lives.
Telephus was founded in 2012 and is based in San Diego, California.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.